Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02221557 · ClinicalTrials.gov registry record · NA
Case Series of New Alloplastic Bone Graft Material
A NA study, sponsored by Sunstar Americas.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02221557 is a NA study that has completed, run by Sunstar Americas. The registered enrollment target is 8 participants.
The verdict
NCT02221557, a NA study, has completed, sponsored by Sunstar Americas.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
A case series to compare the handling and effectiveness of two different treatment approaches using a new alloplastic bone graft material in ridge preservation compared to allograft existing historical data.
Interventions
- DEVICE easy-graft (beta-Tricalcium Phosphate)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2015-03 |
| Est. Completion | 2016-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02221557
The ClinicalTrials.gov registry entry for NCT02221557 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sunstar Americas, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which easy-graft (beta-Tricalcium Phosphate) is the first listed.
NCT02221557 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02221557 about?
NCT02221557 is a clinical study titled "Case Series of New Alloplastic Bone Graft Material". A case series to compare the handling and effectiveness of two different treatment approaches using a new alloplastic bone graft material in ridge preservation compared to allograft existing historical data.
What is the current status of trial NCT02221557?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2015-03. Estimated completion is 2016-06.
What interventions are being tested in trial NCT02221557?
The interventions under investigation include: easy-graft (beta-Tricalcium Phosphate) (DEVICE).
Who is sponsoring clinical trial NCT02221557?
This trial is sponsored by Sunstar Americas, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.